{site_meta && site_meta.display_name} Logo

InvestorBrandNetwork (IBN)

The latest articles, editorials and news releases from InvestorBrandNetwork (IBN), a growing Investor Brand Platform.

RSS Feed for InvestorBrandNetwork (IBN)

InvestorNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Poised in the Future of Cardiac Care with Breakthrough Technology

November 19, 2025 — HeartBeam (NASDAQ: BEAT) is on the verge of transforming how atrial fibrillation (“AF”) is detected and managed with its cable-free ECG technology. A recent article discussing this reads, “HeartBeam has developed a credit card-sized device and proprietary synthesis software that can capture heart signals in three dimensions and convert them into a full synthesized 12-lead ECG.

InvestorNewsBreaks – Soligenix Inc. (NASDAQ: SNGX) Completes Enrollment for Interim Analysis in Phase 3 FLASH2 Study of HyBryte

November 19, 2025 — Soligenix (NASDAQ: SNGX), a late-stage biopharmaceutical company developing treatments for rare diseases with unmet medical need, completed enrollment of the 50 patients required for the interim analysis in its 80-patient confirmatory Phase 3 FLASH2 study evaluating HyBryte (TM) in cutaneous T-cell lymphoma. The interim analysis is slated for the second quarter of 2026, with topline data expected in the second half of the year.

GlobalTech Corp. (GLTK) Is Building Scalable Tech Platforms and Has a Diverse Portfolio of AI-Powered Solutions, including Cadnz

November 19, 2025 — Committed to acquiring companies with strong potential, developing and scaling these assets across a variety of industries Among the company’s portfolio is Cadnz, a leading automation platform for the financial services industry Recently, the founder and CEO of Cadnz, Imran Riaz, sat down for an interview where he spoke about his vision for Cadnz, as well as how automation, data intelligence, and smart integrations are reshaping digital lending for banks and credit unions in the U. S.

BioMedNewsBreaks — Soligenix Inc. (NASDAQ: SNGX) Completes Enrollment for Interim Analysis in Phase 3 FLASH2 Study of HyBryte

November 19, 2025 — Soligenix (NASDAQ: SNGX), a late-stage biopharmaceutical company developing treatments for rare diseases with unmet medical need, completed enrollment of the 50 patients required for the interim analysis in its 80-patient confirmatory Phase 3 FLASH2 study evaluating HyBryte (TM) in cutaneous T-cell lymphoma. The interim analysis is slated for the second quarter of 2026, with topline data expected in the second half of the year.

Study identifies Biomarker to Predict Success of Immunotherapy, Chemo for Breast Cancer

November 19, 2025 — Researchers from the University of Illinois Urbana-Champaign have discovered a protein that can predict which breast cancer patients will respond well to chemotherapy and immunotherapy. After conducting genome-wide screening in human cancer cells, the research team found that the FGD3 protein was a promising biomarker in determining chemotherapy and immunotherapy efficacy.

Sulfur-Based Batteries May Increase Range, Eco Credentials of EVs

November 19, 2025 — Sulfur-based batteries are becoming one of the most talked-about ideas in the electric vehicle world. Scientists believe these batteries could one day help electric cars travel far longer distances while also reducing the environmental problems linked to today’s battery production.

Dozens Die as Mining Bridge Collapses in the DRC

November 19, 2025 — According to officials, a minimum of 32 people lost their lives at a cobalt and copper mine in the DR Congo on Sunday. The deaths occurred after the miners overcrowded a temporary bridge built to enable miners cross a flooded trench.

420 with CNW — New Federal Law Gives States Power to Regulate Hemp THC

November 18, 2025 — Cannabis remains illegal in Wisconsin, yet anyone driving through commercial districts could easily assume otherwise. Shops advertising CBD and THC products have multiplied across the state, filling windows with colorful displays of gummies, oils, drinks, and vape cartridges.

TechMediaBreaks – Off The Hook YS Inc. (NYSE American: OTH) Closes $15 Million Initial Public Offering

November 18, 2025 — Off The Hook YS (NYSE American: OTH), a premier yacht and boat wholesaler, closed its initial public offering of 3,750,000 shares at $4. 00 per share for gross proceeds of $15 million, before underwriting discounts and expenses, and granted underwriters a 45-day option to purchase up to 562,500 additional shares; proceeds will be used to service the floorplan, advertise and market inventory, repay a promissory note and provide working capital, and ThinkEquity served as sole book-running manager for the offering.

InvestorNewsBreaks – Datavault AI Inc. (NASDAQ: DVLT) Highlights Strategic Growth Vision Through Datavault Insights

November 18, 2025 — Datavault AI (NASDAQ: DVLT) a leader in real-world asset digitization and valuation, released a new Datavault Insights detailing how its platform verifies, organizes and monetizes complex assets to accelerate capital formation and project advancement. The update outlines how Datavault closes the widening gap between what companies believe their assets represent and what they can actually prove, emphasizing the growing importance of trusted, market-ready data in sectors such as clean energy and infrastructure.

InvestorNewsBreaks – Annovis Bio Inc. (NYSE: ANVS) Secures FDA Type C Meeting to Advance Parkinson’s Disease Dementia Program

November 18, 2025 — Annovis Bio (NYSE: ANVS) a late-stage clinical drug platform company developing therapies for neurodegenerative diseases including Alzheimer’s and Parkinson’s, announced that the FDA has scheduled a Type C meeting in January 2026 to discuss the clinical pathway for buntanetap in Parkinson’s disease dementia. The Company also reaffirmed continued progress in its Phase 3 Alzheimer’s trial, which remains in full regulatory alignment on design, endpoints and patient population.